FDA Approves a New Obesity Drug Poised to Dethrone Wegovy
| | | | | | | | | | | | | | | | |

FDA Approves a New Obesity Drug Poised to Dethrone Wegovy

There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly injectable drug will be sold under the brand name Zepbound. Read more… Visit Site Source:…

Fake Ozempic Has Sent Several People to the Hospital, Health Agency Warns
| | | | | | | | | | | | | | |

Fake Ozempic Has Sent Several People to the Hospital, Health Agency Warns

Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterfeit products. Residents have reportedly been hospitalized with… Read more… Visit Site Source: Gizmodo Author: Ed…